Stay updated with breaking news from Nasdaq Podd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pictet & Cie Europe SA cut its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 37.1% during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 958 shares of the medical instruments supplier’s stock after selling 564 shares during the period. Pictet & […]
Abrdn plc boosted its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 8.0% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 352,988 shares of the medical instruments supplier’s stock after buying an additional 26,289 shares during the period. […]
Insulet (NASDAQ:PODD – Free Report) had its price target cut by Citigroup from $330.00 to $319.00 in a research report released on Monday, FlyOnTheWall reports. A number of other equities research analysts also recently issued reports on the stock. Barclays boosted their price objective on shares of Insulet from $292.00 to $329.00 in a research […]
Jackson Square Capital LLC reduced its stake in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 0.9% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 6,416 shares of the medical instruments supplier’s stock after selling 61 shares during the quarter. Jackson Square Capital […]
GPS Wealth Strategies Group LLC bought a new position in shares of Insulet Co. (NASDAQ:PODD – Free Report) in the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 240 shares of the medical instruments supplier’s stock, valued at approximately $77,000. Other large investors […]